跳至主要内容
临床试验/ISRCTN16442558
ISRCTN16442558已完成未知

Evaluation of the clinical efficacy and safety of Perindopril / Indapamide / Amlodipine fixed-dose combination in single-pill versus free dual therapy at the same dose as the single-pill combination in patients with uncontrolled essential hypertension

Institut de Recherches Internationales Servier (France)0 个研究点目标入组 150 人开始时间: 2012年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Men or women of any ethnic origin > or = 18 years old
  • 2. Uncontrolled hypertension

排除标准

  • 1. Pregnancy, breastfeeding or possibility of becoming pregnant during the study
  • 2. Hypertension known to be resistant to diuretics or ACE inhibitors
  • 3. Secondary hypertension
  • 4. Complicated hypertension
  • 5. Obesity
  • 6. History of renal disease, ventricular rhythm disorders, atrial fibrillation, atrial flutter
  • 7. Diabetes
  • 8. Grapefruit juice is forbidden during the study

研究者

发起方
Institut de Recherches Internationales Servier (France)

相似试验